NCI's RAS Initiative explores progressive techniques for attacking the proteins encoded by mutant varieties of the KRAS gene. A few other KRAS G12C inhibitors are over the heels of sotorasib and are presently getting tested in clinical trials. And you'll find very likely additional to come b